BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21115155)

  • 1. Mouse models of adrenal tumorigenesis.
    Hantel C; Beuschlein F
    Best Pract Res Clin Endocrinol Metab; 2010 Dec; 24(6):865-75. PubMed ID: 21115155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenocortical tumorigenesis in transgenic mice: the role of luteinizing hormone receptor and transcription factors GATA-4 and GATA-61.
    Rahman NA; Kiiveri S; Siltanen S; Levallet J; Kero J; Lensu T; Wilson DB; Heikinheimo MT; Huhtaniemi IT
    Reprod Biol; 2001 Jul; 1(1):5-9. PubMed ID: 14666170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xenograft models for adrenocortical carcinoma.
    Hantel C; Beuschlein F
    Mol Cell Endocrinol; 2016 Feb; 421():28-33. PubMed ID: 26033247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of adrenocortical carcinomas.
    Soon PS; Sidhu SB
    Minerva Endocrinol; 2009 Jun; 34(2):137-47. PubMed ID: 19471238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into the role of genetic alterations in adrenocortical tumorigenesis.
    Herbet M; Feige JJ; Thomas M
    Mol Cell Endocrinol; 2009 Mar; 300(1-2):169-74. PubMed ID: 19007854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward a pathway-centered approach for the treatment of adrenocortical carcinoma.
    Bussey KJ; Demeure MJ
    Curr Opin Oncol; 2011 Jan; 23(1):34-44. PubMed ID: 21045685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the inhibin/activin system and luteinizing hormone in adrenocortical tumorigenesis.
    Beuschlein F; Looyenga BD; Reincke M; Hammer GD
    Horm Metab Res; 2004 Jun; 36(6):392-6. PubMed ID: 15241730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenocortical tumorigenesis.
    Beuschlein F; Reincke M
    Ann N Y Acad Sci; 2006 Nov; 1088():319-34. PubMed ID: 17192577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenocortical tumorigenesis, luteinizing hormone receptor and transcription factors GATA-4 and GATA-6.
    Vuorenoja S; Rivero-Muller A; Kiiveri S; Bielinska M; Heikinheimo M; Wilson DB; Huhtaniemi IT; Rahman NA
    Mol Cell Endocrinol; 2007 Apr; 269(1-2):38-45. PubMed ID: 17337116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathophysiology, diagnosis and prognosis of adrenocortical tumors revisited by transcriptome analyses.
    Assié G; Guillaud-Bataille M; Ragazzon B; Bertagna X; Bertherat J; Clauser E
    Trends Endocrinol Metab; 2010 May; 21(5):325-34. PubMed ID: 20097573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic and expression profiling of adrenocortical carcinoma: application to diagnosis, prognosis and treatment.
    Bussey KJ; Demeure MJ
    Future Oncol; 2009 Jun; 5(5):641-55. PubMed ID: 19519204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of adrenal tumors.
    Opocher G; Schiavi F; Cicala MV; Patalano A; Mariniello B; Boaretto F; Zovato S; Pignataro V; Macino B; Negro I; Mantero F
    Minerva Endocrinol; 2009 Jun; 34(2):107-21. PubMed ID: 19471236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Malignant tumors of the adrenal: contribution to the repository CCAFU INCa].
    Sèbe P; Rigaud J; Avancès C; Brunaud L; Caillard C; Camparo P; Carnaille B; Culine S; Durand X; Mathonnet M; Mirallie E; Soulié M;
    Prog Urol; 2010 Nov; 20 Suppl 4():S310-6. PubMed ID: 21129649
    [No Abstract]   [Full Text] [Related]  

  • 14. Adrenocortical carcinoma: clinical and laboratory observations.
    Wajchenberg BL; Albergaria Pereira MA; Medonca BB; Latronico AC; Campos Carneiro P; Alves VA; Zerbini MC; Liberman B; Carlos Gomes G; Kirschner MA
    Cancer; 2000 Feb; 88(4):711-36. PubMed ID: 10679640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular markers and the pathogenesis of adrenocortical cancer.
    Soon PS; McDonald KL; Robinson BG; Sidhu SB
    Oncologist; 2008 May; 13(5):548-61. PubMed ID: 18515740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal models of adrenocortical tumorigenesis.
    Galac S; Wilson DB
    Endocrinol Metab Clin North Am; 2015 Jun; 44(2):297-310. PubMed ID: 26038202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenocortical cancer: pathophysiology and clinical management.
    Libè R; Fratticci A; Bertherat J
    Endocr Relat Cancer; 2007 Mar; 14(1):13-28. PubMed ID: 17395972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis.
    Tömböl Z; Szabó PM; Molnár V; Wiener Z; Tölgyesi G; Horányi J; Riesz P; Reismann P; Patócs A; Likó I; Gaillard RC; Falus A; Rácz K; Igaz P
    Endocr Relat Cancer; 2009 Sep; 16(3):895-906. PubMed ID: 19546168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent data in adrenocortical tumorigenesis].
    Crand A; Borson-Chazot F; Brue T
    Ann Endocrinol (Paris); 2009 Sep; 70 Suppl 1():S20-5. PubMed ID: 19878765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular pathogenesis of hereditary and sporadic adrenocortical and adrenomedullary tumors.
    Koch CA; Pacak K; Chrousos GP
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5367-84. PubMed ID: 12466322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.